Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,306 total articles
Artiva Biotherapeutics (ARTV) is an actionable buy ahead of rheumatoid arthritis clinical readouts and expected FDA alignment. The company carries a modest market cap (~$269M) with a reported cash runway into Q2 2027 and Fast Track designation for AlloNK in refractory RA. Successful proof-of-concept or clear regulatory guidance would materially re-…
Nano Labs is a microcap semiconductor and AI-infrastructure play that has aggressively pivoted into crypto reserves and BNB Chain tokenization while keeping its chip design credentials. The market is punishing the stock near $1.73, but a low $40M market cap, insider buying and concrete strategic initiatives (NBNB program; MoU on North America AI da…
Uber’s pivot from building autonomous cars in-house to coordinating fleets and technology partners positions the company as a gatekeeper for the robotaxi era. Strong Q1 results, rising membership and capital-light robotaxi deals give Uber optionality without the cash burn of vehicle development. I like a controlled long into recent weakness with a …
Cheniere (LNG) trades below short-term moving averages but sits on durable cash generation and a direct play on a widened Henry Hub - TTF arbitrage. With $2.46B in trailing free cash flow, EV/EBITDA ~7.1 and a market cap near $50.5B, the risk/reward favors a long trade into $300 over the next 180 trading days, with a disciplined $225 stop.
IREN's announced partnership with Nvidia transforms the company from a niche infrastructure provider into a potential AI-hardware and services play. The agreement accelerates recurring revenue, raises gross-margin potential and creates near-term commercial catalysts. We lay out an actionable swing trade: enter at $15.00, stop at $11.00, target $27.…
Canadian Natural Resources (CNQ) combines a durable dividend, low valuation (P/E ~12), and strong operating cash flow to support upside from current levels. We recommend a tactical long with an entry at $44.70, stop at $41.50 and target at $51.00 over a mid-term horizon (45 trading days). Risks include commodity-price swings, regulatory pressure on…
Blue Owl pays a hefty quarterly distribution ($0.23) that implies an ~8.7% yield and is trading well below its 52-week high. The combination of a large dividend, fee-bearing asset base, and recent asset purchases creates a tactical long trade: enter around $10.40, stop at $9.00 and target $15.00 over a mid-term horizon (45 trading days). The trade …
NIO has moved from growth-at-all-costs to profitable growth. Recent profitable quarters, a rising premium mix, and new hardware partnerships make the market's skepticism excessive. This trade idea targets a re-rating toward the $8 area over the next 45 trading days while keeping risk controlled with a tight stop at $4.80.
ServiceTitan's push to embed AI across its field-service platform is increasing operator stickiness and expanding monetization opportunities. We view near-term adoption metrics and product-led revenue levers as the primary drivers for a mid-term long trade. Entry at $30.00, target $40.00, stop $25.00 — plan horizon: mid term (45 trading days).
Everforth’s stock has retraced sharply from 52-week highs into bargain territory. With a market cap near $832M, P/E ~9.2 and tangible book value that implies meaningful upside, this trade targets a rebound driven by valuation rerating and stabilization in short activity. Entry, stop and target provided for a mid-term swing trade (45 trading days).
AngloGold Ashanti looks positioned to deliver outsized free cash flow as the gold price stabilizes. With operating leverage, disciplined capital allocation, and a technical consolidation that favors an upside breakout, this trade targets a measured re-rating while keeping defined risk management.
Texas Roadhouse looks healthy operationally but its recent bounce masks unresolved downside risk. We upgrade to a tactical buy on weakness: enter on a pullback, keep a tight stop, and target a breakout above the prior 52-week high. Valuation is fair for a high-return operator, but execution and traffic trends will determine whether the stock escape…
Micron's business just moved from cyclical to structural thanks to AI-driven demand for HBM and SSDs. Revenue and margins are explosive, valuation looks rich on some metrics but reasonable against runaway top-line growth. This trade idea lays out a clear long position with entry at $720, a stop at $600 and a primary target at $900 over a multimonth…
NetScout delivered a surprise Q4 and is showing fundamentals that justify an upgrade to positive. Valuation looks reasonable on a cash-flow basis, and key catalysts - product leadership, rising market demand for deep observability, and improving guidance - could push shares higher over the next 3-6 months. Trade plan included with entry, stop, and …
Broadcom's combination of semiconductor strength and rapidly expanding infrastructure software gives the company a unique footing in the AI infrastructure cycle. With free cash flow of $28.9B and a market cap near $2.01T, AVGO trades richly but with earnings and deal-news catalysts that can re-rate the stock. This trade idea lays out a mid-term lon…
Ardelyx trades at $7.09 with a market cap around $1.75B and EV roughly $1.86B. On implied revenue of about $408M (market cap / P/S 4.23), the stock prices in rapid growth and margin expansion. Fundamentals - negative EPS (-$0.25), negative free cash flow (-$43.98M), and debt-to-equity of 1.21 - argue that the current valuation is vulnerable to exec…
After a 40-50% run in 2026, Barry Callebaut remains a tradeable name rather than a buy-and-forget. I outline a mid-term (45 trading days) swing-long setup with precise entry, target and stop, driven by seasonal demand, margin leverage and potential positive guidance, while acknowledging cocoa price and FX risks.
Landmark Bancorp (LARK) reported strong FY 2025 results (EPS ~$3.07) with margin expansion, improved credit metrics and a tangible book value lift. At an 8x multiple (~$24.64), the stock offers an asymmetric risk/reward: attractive yield, healthy cash flow and conservative leverage. This trade targets a disciplined entry on pullback, with a long-te…
Alphabet sits at the center of the generative-AI wave, but its investment case does not require an unqualified 'win' in the model wars. Search advertising, YouTube, Android, and Cloud create a multi-legged business that benefits from AI regardless of which large language model captures headlines. This trade idea offers a long trade with defined ent…
Alphabet reported metrics that validate our view: strong earnings power, sizeable free cash flow and high-return assets. Valuation is full but not extreme for a company with dominant ad economics and accelerating cloud monetization. We lay out a mid-term trade plan to capture continued upside while respecting near-term technical overbought signals.
The Andersons (ANDE) blends a stable agribusiness cash engine with an improving renewables franchise. With a $2.41B market cap, P/E ~18.8 and EV/EBITDA 13.5, the stock looks reasonably valued. New 45Z-style tax credits aimed at renewable fuel projects materially improve the economics of ethanol and co-product facilities - a direct benefit to Anders…
OceanaGold (OGC) looks positioned to outpace peers over the next 45 trading days. The company trades at a modest PE of 9.1, operates four producing assets across high-quality jurisdictions, and shows a technical/flow backdrop that could accelerate a rally toward prior highs. This trade idea lays out an entry at $31.78, a $38.00 target, and a $28.50…
POET plunged after confidentiality and disclosure issues around a customer order triggered lawsuits and a lost $5 million contract, but the core optical interposer technology addresses clear AI data-center pain points. With a $1.63B market cap, revenue still tiny ($1.07M in 2025) and heavy losses ($42.1M in 2025), this is speculative. Technicals ar…
Oklo is a pre-revenue microreactor developer with a heavy institutional following, a clean balance sheet and multiple strategic partnerships. Q1 results and near-term regulatory signals create a clear binary setup. Buy a tactical position at current levels with a strict stop — the risk/reward is favorable for a mid-term swing if management provides…
Hewlett Packard Enterprise's integration of Juniper is starting to show up in results and product momentum. Recent Q1 beats, raised EPS guidance and the launch of Juniper-powered SRX400 AI Security firewalls support a mid-term long trade at $29.94 with a $36 target and $26 stop. Valuation is reasonable (market cap ~$39.7B, EV/EBITDA ~13.7) and free…
